Clinical trial
A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults With Essential Tremor
NCT05021978 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults With Essential Tremor
- Lead sponsor
- Praxis Precision Medicines
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 3, 2020
- Completion date
- March 24, 2022
- Enrollment
- 24 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.